ProMIS Neurosciences, Inc. (PMN)
 NASDAQ: PMN · Real-Time Price · USD
 0.4177
 +0.0017 (0.41%)
  At close: Oct 30, 2025, 4:00 PM EDT
0.4260
 +0.0083 (1.99%)
  After-hours: Oct 30, 2025, 7:57 PM EDT
ProMIS Neurosciences Employees
As of December 31, 2024, ProMIS Neurosciences had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year.
Employees 
 8
Change (1Y) 
 1
Growth (1Y) 
 14.29%
Revenue / Employee 
 n/a
Profits / Employee 
 -$1,053,414
Market Cap 
22.48M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 8 | 1 | 14.29% | 
| Dec 31, 2023 | 7 | 0 | - | 
| Dec 31, 2022 | 7 | 1 | 16.67% | 
| Dec 31, 2021 | 6 | 5 | 500.00% | 
| Dec 31, 2020 | 1 | - | - | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
PMN News
- 8 days ago - ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group - GlobeNewsWire
- 2 months ago - ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer's Trial of PMN310 - GlobeNewsWire
- 2 months ago - ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights - GlobeNewsWire
- 3 months ago - ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer's Association International Conference - GlobeNewsWire
- 3 months ago - ProMIS Neurosciences Announces Private Placement Financing - GlobeNewsWire
- 3 months ago - ProMIS Neurosciences Granted Fast Track Designation by U.S. FDA for PMN310 in the Treatment of Alzheimer's Disease - GlobeNewsWire
- 4 months ago - ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference - GlobeNewsWire
- 6 months ago - ProMIS Neurosciences Announces First Quarter 2025 Financial Results - GlobeNewsWire